U.S. Physical Therapy, Inc. - Q1 2004 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended March 31, 2004. U.S. Physical Therapy, Inc. operates outpatient physical and occupational therapy clinics providing pre- and post-operative care. As of the reporting date, the company operated 244 clinics across 35 states. The company primarily develops new clinics rather than acquiring existing ones, with a goal to open between 45 and 50 new clinics in 2004.
Key Financial Metrics
| Metric | Q1 2004 | Q1 2003 |
|---|---|---|
| Net Revenues | $28.3 million | $25.0 million |
| Net Income | $1.5 million | $1.8 million |
| Diluted EPS | $0.13 | $0.15 |
| Operating Cash Flow | $3.2 million | $4.5 million |
| Cash and Equivalents | $18.4 million | $10.1 million |
| Total Debt | $1.7 million (Convertible Notes) | $2.3 million (Convertible Notes) |
| Current Ratio | 6.27:1 | N/A |
| Debt-to-Equity | 0.04:1 | 0.06:1 |
Material Changes vs. Prior Period
- Revenue Growth: Net revenues increased 13% to $28.3 million, driven by a 9% increase in patient visits (290,248 vs. 265,502) and a 3.6% increase in revenue per visit ($95.49 vs. $92.21).
- Profitability Decline: Despite revenue growth, Net Income decreased 14% to $1.5 million. Operating income fell to $3.7 million from $4.1 million due to rising operating costs.
- Cost Increases: Clinic operating costs rose to 74% of net revenues (from 71%). Salaries and related costs increased 19% due to new clinic openings and higher health insurance costs. Rent and supplies increased 17%.
- Operational Efficiency: Average visits per day per clinic declined from 20.5 in Q1 2003 to 18.7 in Q1 2004, attributed to the ramp-up period of new clinics.
- Debt Reduction: Convertible subordinated notes payable decreased from $2.3 million to $1.7 million following a conversion of $667,000 into common stock in January 2004.
Outlook, Risks, and Management Commentary
- Guidance: Management aims to open 45 to 50 new clinics in 2004. New clinics are expected to incur initial operating losses, impacting near-term margins.
- Medicare Limit Risk: Approximately 19% of revenue is derived from Medicare. A moratorium on the $1,590 annual reimbursement limit is in place through 2005. If the moratorium expires in 2006 without extension, revenue could be adversely impacted.
- Debt Maturity: The remaining $1.7 million in Series C Convertible Notes matures in June 2004. Conversion depends on the share price being at or above $3.33; otherwise, the company must repay the balance in cash.
- Liquidity: The company maintains strong liquidity with $18.4 million in cash and a current ratio of 6.27. Management believes existing cash flows are sufficient to fund operations and development through 2005.
Investor Verification Checklist
- Verify the status of the Medicare reimbursement moratorium and potential impact on 2006 revenue if not extended.
- Monitor the share price relative to $3.33 prior to the June 2004 maturity of the convertible notes to assess cash repayment risk.
- Track the ramp-up timeline for new clinics to determine when they will transition from losses to profitability.
- Review the trend in visits per day per clinic to assess if the decline is temporary due to expansion or indicative of broader market saturation.
- Confirm the conversion of the remaining $1.7 million debt in the subsequent filing (Q2 2004).